Cambridge have extended their dominance of the men’s Boat Race, overcoming some of the most choppy and windy conditions in ...
With a second oral GLP-1 for obesity now approved in the U.S., analysts have set to work parsing the blockbuster potential of ...
Pharmaceutical Technology on MSN
Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry
Lilly’s product, known under the brand name Foundayo, has a clear route to early blockbuster status.
The course stretches over 4.25 miles (6.8km) of tidal Thames from Putney to Mortlake, commonly referred to as the ...
Keurig Dr Pepper Inc. named Rafael Oliveira, chief executive officer of recently acquired JDE Peet’s NV, to lead the ...
Live Updates US FDA Just Approved Eli Lilly’s GLP-1 Pill 16 minutes ago Live Shares of LLY are up about $40 a share after the ...
Pact includes Zuellig Pharma getting exclusive rights to make erectile dysfunction drug Cialis in Singapore Read more at The ...
The local high school track and field scene will shift to Oak Hill this week for the Oak Hill High School Invitational. For ...
China’s NMPA is the gatekeeper to a trillion dollar healthcare market, and Audeara has just found a way in. ... Read More The post Move over FDA: Crack NMPA and unlock China – Audeara makes its move ...
Foundayo is Eli Lilly’s once-daily oral GLP-1 prescription for chronic weight management. As of April 2026, cash pay was reported at $149 to $349 per month, with the total moving based on dose ...
The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold ...
Indianapolis-based Eli Lilly and Co. announced plans to acquire UK-based Centessa Pharmaceuticals in a deal worth up to $7.8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results